KCNN4 and asthma: The intermediate conductance Ca2+-activated K+ channel KCa3.1 inhibits the proliferation and migration of several cell types, effects which may be detrimental if applicable to the damaged airway epithelium in diseases such as asthma and idiopathic pulmonary fibrosis.